High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein

Kidney International

Volumn 78, Issue 1, 2010, Pages 48-59

  Isoe, Tsubasa ^a   Makino, Yuichi ^a   Mizumoto, Katsutoshi ^a   Sakagami, Hidemitsu ^a   Fujita, Yukihiro ^a   Honjo, Jun ^a   Takiyama, Yumi ^a   Itoh, Hiroshi ^a   Haneda, Masakazu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Diabetic glomerulopathy; Mesangial cells; Transcription factors

Indexed keywords

BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UNCLASSIFIED DRUG; HYPOXIA INDUCIBLE FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; ANIMAL; ANOXIA; C57BL MOUSE; CELL CULTURE; CELL NUCLEUS; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; UPREGULATION;

ANIMALS; ANOXIA; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLUCOSE; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MESANGIAL CELLS; MICE; MICE, INBRED C57BL; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 77953688069     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.99     Document Type: Article

References (56)

1. Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008; 4: 444-452.
2. Schernthaner G. Kidney disease in diabetology: lessons from 2007. Nephrol Dial Transplant 2008; 23: 1112-1115.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
4. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
5. Fioretto P, Steffes MW, Sutherland DE et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75. (Pubitemid 28304880)
6. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1358-1373.
7. Gnudi L, Viberti G, Raij L et al. GLUT-1 overexpression: link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003; 42: 19-24.
8. Mueller PW, Rogus JJ, Cleary PA et al. Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2006; 17: 1782-1790.
9. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int 2000; 58(Suppl 77): S3-S12.
10. Schleicher ED, Weigert C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int 2000; 58(Suppl 77): S13-S18.
11. Forbes JM, Cooper ME, Oldfield MD et al. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003; 14: S254-S258.
12. Kiritoshi S, Nishikawa T, Sonoda K et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003; 52: 2570-2577.
13. Haneda M, Koya D, Kikkawa R. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis 2001; 38(4 Suppl 1): S178-S181.
14. Murphy M, Godson C, Cannon S et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274: 5830-5834.
15. Haneda M, Koya D, Isono M et al. Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 2003; 14: 1374-1382.
16. Lee HB, Ha H. Plasminogen activator inhibitor-1 and diabetic nephropathy. Nephrology 2005; 10: S11-S13.
17. 2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
18. Jiang BH, Rue E, Wang GL et al. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996; 271: 17771-17778.
19. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
20. Higgins DF, Biju MP, Akai Y et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 28: 1223-1232.
21. Riddle SR, Ahmad A, Ahmad S et al. Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am J Physiol Lung Cell Mol Physiol 2000; 278: 407-416.
22. Wood MS, Wiesener MS, Yeates KM et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1a-subunit (HIF-1a): characterization of HIF-1a-dependent and-independent hypoxia-inducible gene expression. J Biol Chem 1998; 273: 8360-8368.
23. Kietzmann T, Roth U, Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999; 94: 4177-4185.
24. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
25. Epstein AC, Gleadle JM, McNeill LA et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
26. Kallio PJ, Okamoto K, O'Brien S et al. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1a. EMBO J 1998; 17: 6573-6586.
27. McMahon S, Charbonneau M, Grandmont S et al. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem 2006; 281: 24171-24181.
28. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1a in vascular smooth muscle cells. J Biol Chem 2000; 275: 26765-26771.
29. Isaacs JS, Jung YJ, Mole DR et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 2005; 8: 143-153.
30. Haddad JJ, Land SC. A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1a. FEBS Lett 2001; 505: 269-274.
31. Pagé EL, Robitaille GA, Pouysségur J et al. Induction of hypoxia-inducible factor-1a by transcriptional and translational mechanisms. J Biol Chem 2002; 277: 48403-48409.
32. Makino H, Miyamoto Y, Sawai K et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006; 55: 2747-2756.
33. El-Nahas AM. Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int 2003; 64: 1553-1563.
34. Morrison AA, Viney RL, Saleem MA et al. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 2008; 295: F12-F17.
35. Krause DS, Fackler MJ, Civin CI et al. CD34: structure, biology, and clinical utility. Blood 1996; 87: 1-13.
36. Cooker LA, Peterson D, Rambow J et al. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 2007; 293: F157-F165.
37. Kallio PJ, Wilson WJ, O'Brien S et al. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem 1999; 274: 6519-6525.
38. Pescador N, Cuevas Y, Naranjo S et al. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 2005; 390: 189-197.
39. Nakayama K, Gazdoiu S, Abraham R et al. Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem J 2007; 401: 217-226.
40. Iyer NV, Leung SW, Semenza GL. The human hypoxia-inducible factor 1a gene: HIF1a structure and evolutionary conservation. Genomics 1998; 52: 159-165.
41. Uyeda K, Repa JJ. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab 2006; 4: 107-110.
42. Rosenberger C, Heyman SN, Rosen S et al. Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int 2005; 67: 531-542.
43. Nangaku M, Inagi R, Miyata T et al. Hypoxia and hypoxia-inducible factor in renal disease. Nephron Exp Nephrol 2008; 110: e1-e7.
44. Ding M, Cui S, Li C et al. Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. Nat Med 2006; 12: 1081-1087.
45. Tesch GH, Allen TJ. Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology 2007; 12: 261-266.
46. Cohen MP, Clements RS, Hud E et al. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp Nephrol 1996; 4: 166-171.
47. Pfäfflin A, Brodbeck K, Heilig CW et al. Increased glucose uptake and metabolism in mesangial cells overexpressing glucose transporter 1 increases interleukin-6 and vascular endothelial growth factor production: role of AP-1 and HIF-1a. Cell Physiol Biochem 2006; 18: 199-210.
48. Yamashita H, Takenoshita M, Sakurai M et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98: 9116-9121.
49. Catrina SB, Okamoto K, Pereira T et al. Hyperglycemia regulates hypoxia-inducible factor-1a protein stability and function. Diabetes 2004; 53: 3226-3232.
50. Katavetin P, Miyata T, Inagi R et al. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol 2006; 17: 1405-1413.
51. Guo S, Bragina O, Xu Y et al. Glucose up-regulates HIF-1alpha expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status. J Neurochem 2008; 105: 1849-1860.
52. Noordeen NA, Khera TK, Sun G et al. ChREBP is a negative regulator of ARNT/HIF-1b gene expression in pancreatic Islet b-cells. Diabetes 2010; 59: 153-160.
53. Jögi A, Øra I, Nilsson H et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002; 99: 7021-7026.
54. Makino Y, Uenishi R, Okamoto K et al. Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 2007; 282: 14073-14082.
55. Makino Y, Nakamura H, Ikeda E et al. Hypoxia-inducible factor regulates survival of antigen receptor-driven T cells. J Immunol 2003; 15: 6534-6540.
56. Christel B, Ester P, Igor A et al. Retrograde signaling onto Ret during motor nerve terminal maturation. J Neurosci 2008; 28: 963-975.